These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 18801902)
61. Molecular characterization of feline melanocortin 4 receptor and melanocortin 2 receptor accessory protein 2. Habara M; Mori N; Okada Y; Kawasumi K; Nakao N; Tanaka Y; Arai T; Yamamoto I Gen Comp Endocrinol; 2018 May; 261():31-39. PubMed ID: 29360464 [TBL] [Abstract][Full Text] [Related]
62. Melanocortin 4 receptor mutations in obese Czech children: studies of prevalence, phenotype development, weight reduction response, and functional analysis. Hainerová I; Larsen LH; Holst B; Finková M; Hainer V; Lebl J; Hansen T; Pedersen O J Clin Endocrinol Metab; 2007 Sep; 92(9):3689-96. PubMed ID: 17579204 [TBL] [Abstract][Full Text] [Related]
63. Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects. Tao YX; Segaloff DL J Clin Endocrinol Metab; 2005 Oct; 90(10):5632-8. PubMed ID: 16030156 [TBL] [Abstract][Full Text] [Related]
64. Alanine Scanning Mutagenesis of the DRYxxI Motif and Intracellular Loop 2 of Human Melanocortin-4 Receptor. Yang LK; Tao YX Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076233 [TBL] [Abstract][Full Text] [Related]
65. High affinity agonistic metal ion binding sites within the melanocortin 4 receptor illustrate conformational change of transmembrane region 3. Lagerström MC; Klovins J; Fredriksson R; Fridmanis D; Haitina T; Ling MK; Berglund MM; Schiöth HB J Biol Chem; 2003 Dec; 278(51):51521-6. PubMed ID: 14523020 [TBL] [Abstract][Full Text] [Related]
66. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Tao YX Mol Cell Endocrinol; 2005 Jul; 239(1-2):1-14. PubMed ID: 15975705 [TBL] [Abstract][Full Text] [Related]
67. A Novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity. Kobayashi H; Ogawa Y; Shintani M; Ebihara K; Shimodahira M; Iwakura T; Hino M; Ishihara T; Ikekubo K; Kurahachi H; Nakao K Diabetes; 2002 Jan; 51(1):243-6. PubMed ID: 11756348 [TBL] [Abstract][Full Text] [Related]
68. Pharmacological chaperone action in humanized mouse models of MC4R-linked obesity. René P; Lanfray D; Richard D; Bouvier M JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33434184 [TBL] [Abstract][Full Text] [Related]
69. Molecular characterization of human melanocortin-5 receptor ligand-receptor interaction. Yang Y; Mishra VK; Chen M; Duffee E; Dimmitt R; Harmon CM Biochemistry; 2013 Mar; 52(10):1737-45. PubMed ID: 23414113 [TBL] [Abstract][Full Text] [Related]
70. Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Biebermann H; Krude H; Elsner A; Chubanov V; Gudermann T; Grüters A Diabetes; 2003 Dec; 52(12):2984-8. PubMed ID: 14633860 [TBL] [Abstract][Full Text] [Related]
71. A two-base deletion -439delGC in the melanocortin-4 receptor promoter associated with early-onset obesity. Valli-Jaakola K; Palvimo JJ; Lipsanen-Nyman M; Salomaa V; Peltonen L; Kontula K; Schalin-Jäntti C Horm Res; 2006; 66(2):61-9. PubMed ID: 16710097 [TBL] [Abstract][Full Text] [Related]
73. Structural and signaling requirements of the human melanocortin 4 receptor for MAP kinase activation. Patten CS; Daniels D; Suzuki A; Fluharty SJ; Yee DK Regul Pept; 2007 Aug; 142(3):111-22. PubMed ID: 17376547 [TBL] [Abstract][Full Text] [Related]
74. Functional Characterization of Novel Mohammed I; Selvaraj S; Ahmed WS; Al-Barazenji T; Hammad AS; Dauleh H; Saraiva LR; Al-Shafai M; Hussain K Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003551 [TBL] [Abstract][Full Text] [Related]
75. Low frequency of melanocortin-4 receptor (MC4R) mutations in a Mediterranean population with early-onset obesity. Miraglia Del Giudice E; Cirillo G; Nigro V; Santoro N; D'Urso L; Raimondo P; Cozzolino D; Scafato D; Perrone L Int J Obes Relat Metab Disord; 2002 May; 26(5):647-51. PubMed ID: 12032748 [TBL] [Abstract][Full Text] [Related]
76. Molecular determinants of ligand binding to the human melanocortin-4 receptor. Yang YK; Fong TM; Dickinson CJ; Mao C; Li JY; Tota MR; Mosley R; Van Der Ploeg LH; Gantz I Biochemistry; 2000 Dec; 39(48):14900-11. PubMed ID: 11101306 [TBL] [Abstract][Full Text] [Related]
77. Prevalence of pathogenetic MC4R mutations in Italian children with early onset obesity, tall stature and familial history of obesity. Santoro N; Cirillo G; Xiang Z; Tanas R; Greggio N; Morino G; Iughetti L; Vottero A; Salvatoni A; Di Pietro M; Balsamo A; Crinò A; Grandone A; Haskell-Luevano C; Perrone L; del Giudice EM BMC Med Genet; 2009 Mar; 10():25. PubMed ID: 19284607 [TBL] [Abstract][Full Text] [Related]
78. Melanocortin 3 receptor gene and melanocortin 4 receptor gene mutations: the Asian Perspective. Lee YS Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():26-31. PubMed ID: 23280863 [TBL] [Abstract][Full Text] [Related]
79. High prevalence of leptin and melanocortin-4 receptor gene mutations in children with severe obesity from Pakistani consanguineous families. Saeed S; Butt TA; Anwer M; Arslan M; Froguel P Mol Genet Metab; 2012 May; 106(1):121-6. PubMed ID: 22463805 [TBL] [Abstract][Full Text] [Related]
80. Novel binding motif of ACTH analogues at the melanocortin receptors. Yang Y; Hruby VJ; Chen M; Crasto C; Cai M; Harmon CM Biochemistry; 2009 Oct; 48(41):9775-84. PubMed ID: 19743876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]